Suchergebnisse - "DAI YAZHUANG"

PubPharm (8)

1

Medical application of N-benzene substituted-2-hypoxanthine thioacetamide derivative in resisting mycobacterium tuberculosis infection

enthalten in: Europäisches Patentamt | 2021

von LIN KEJIANG | DAI YAZHUANG | XU YINQIU

2

Medical application of N-substituted-2-hypoxanthine thioacetamide derivative in resisting mycobacterium tuberculosis infection

enthalten in: Europäisches Patentamt | 2021

von LIN KEJIANG | DAI YAZHUANG | XU YINQIU

3

Medical application of 2-(pyridine-2-thioxo) acetic acid in anti-mycobacterium tuberculosis infection

enthalten in: Europäisches Patentamt | 2021

von LIN KEJIANG | DAI YAZHUANG | XU YINQIU

4

Suramin Targets the Conserved Ligand-Binding Pocket of Human Raf1 Kinase Inhibitory Protein

enthalten in: Molecules (Basel, Switzerland) | 2021

von Guo, C. | Wu, Z. | Lin, W. | +4

5

Discovery and evaluation of new compounds targeting ribosomal protein S1 in antibiotic-resistant Mycobacterium Tuberculosis

enthalten in: European journal of medicinal chemistry | 2020

von Dai, Y. | Xu, Y. | Guo, C. | +3

6

Lead compounds and key residues of ribosomal protein S1 in drug-resistant Mycobacterium tuberculosis

enthalten in: Bioorganic chemistry | 2019

von Zhi, Y. | Dai, Y. | Yang, J. | +3

7

Anti-leprosy drug Clofazimine binds to human Raf1 kinase inhibitory protein and enhances ERK phosphorylation

enthalten in: Acta biochimica et biophysica Sinica | 2018

von Guo, C. | Chang, T. | Sun, T. | +4

8

Structural basis for ribosome protein S1 interaction with RNA in trans-translation of Mycobacterium tuberculosis

enthalten in: Biochemical and biophysical research communications | 2017

von Fan, Y. | Dai, Y. | Hou, M. | +5

1
[1]